Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceuticals targeting cancer pathways. Its structure supports the development of compounds with high selectivity for tyrosine kinase receptors, making it valuable in drug discovery for oncology. The fluorinated indolinone core enhances metabolic stability and binding affinity in active pharmaceutical ingredients. It is also employed in research for designing novel bioactive molecules with improved pharmacokinetic properties.